Skip to main content
. 2019 Aug 15;14(9):1372–1380. doi: 10.2215/CJN.00020119

Table 2.

Performances of eGFR and functional magnetic resonance imaging measurements for the differentiation of ≤25% versus >25% interstitial fibrosis and >50% versus ≤50% interstitial fibrosis among kidney transplant patients with allograft injury

Measurements Correlations with Interstitial Fibrosis ≤25% versus >25% Interstitial Fibrosis >50% versus ≤50% Interstitial Fibrosis
Cutoff AUC (95% CI) Sensitivity (95% CI) Specificity (95% CI) Cutoff AUC (95% CI) Sensitivity (95% CI) Specificity (95% CI)
Apparent diffusion coefficient rho=−0.77; P<0.001 1.99×10−3mm2/s 0.87 (0.79 to 0.93) 76% (62% to 87%) 84% (70% to 93%) 1.91×10−3mm2/s 0.88 (0.80 to 0.93) 86% (64% to 97%) 72% (61% to 81%)
Arterial spin labeling rho=−0.83;; P<0.001 101 ml/min per 100 g 0.92 (0.85 to 0.97) 94% (85% to 99%) 78% (63% to 88%) 82.9 ml/min per 100 g 0.94 (0.87 to 0.98) 95% (76% to 99.9%) 87% (77% to 93%)
Perfusion fraction rho=−0.66 P<0.001 0.299 0.81 (0.72 to 0.88)a 76% (62% to 87%) 78% (63% to 88%) 0.285 0.86 (0.78 to 0.92) 91% (70% to 99%) 72% (61% to 81%)
BOLD rho=0.61; P<0.001 18.10 Hz 0.79 (0.69 to 0.87)b 79% (64% to 89%) 72% (57% to 84%) 18.14 Hz 0.85 (0.76 to 0.92) 91% (70% to 99%) 69% (58% to 80%)
eGFRc rho=−0.79; P<0.001 38 ml/min per 1.73 m2 0.91 (0.84 to 0.96) 91% (80% to 97%) 78% (63% to 88%) 38 ml/min per 1.73 m2 0.91 (0.84 to 0.96) 95% (76% to 99.9%) 72% (61% to 81%)
eGFRd rho=−0.79; P<0.001 38 ml/min per 1.73 m2 0.93 (0.85 to 0.97) 89% (77% to 97%) 83% (69% to 92%) 38 ml/min per 1.73 m2 0.90 (0.82 to 0.95) 95% (76% to 99.9%) 68% (56% to 79%)

eGFR calculated by the CKD Epidemiology Collaboration equation AUC, area under the curve; 95% CI, 95% confidence interval; BOLD, blood oxygen level–dependent.

a

Represented P<0.05 by comparing the AUC of perfusion fraction to that of eGFR.

b

Denoted P<0.01 by comparing the AUC of BOLD to that of eGFR.

c

Indicated that data were analyzed from all 103 patients with allograft injury.

d

Denoted that data were analyzed from 93 patients with BOLD results.